Samanta Capolicchio Selected Research

Salicylamides

1/2019

SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samanta Capolicchio Research Topics

Disease

2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2018
1	Leukemia 01/2019

Drug/Important Bio-Agent (IBA)

1	Carrier Proteins (Binding Protein)IBA 01/2019
1	SalicylamidesIBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Niclosamide FDA Link 01/2018
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2018